Appendix 2—table 27. Statin User Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Statin Users by BP: Unmatched | Region=NY Statin Users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 185,536 | 100.0% | 161,673 | 87.1% | 23,863 | 12.9% | 47,472 | 100.0% | 23,736 | 50.0% | 23,736 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 67 | 0.0% | 67 | 0.0% | 0 | 0.0% | <0.001 | 52 | 0.1% | 26 | 0.1% | 26 | 0.1% | 1.00 |
| 21-40 | 4,511 | 2.4% | 4,485 | 2.8% | 26 | 0.1% | 304 | 0.6% | 152 | 0.6% | 152 | 0.6% | ||
| 41-50 | 15,440 | 8.3% | 15,288 | 9.5% | 152 | 0.6% | 4,381 | 9.2% | 2,192 | 9.2% | 2,189 | 9.2% | ||
| 51-60 | 43,068 | 23.2% | 40,879 | 25.3% | 2,189 | 9.2% | 14,717 | 31.0% | 7,358 | 31.0% | 7,359 | 31.0% | ||
| 61-70 | 53,227 | 28.7% | 45,861 | 28.4% | 7,366 | 30.9% | 18,189 | 38.3% | 9,092 | 38.3% | 9,097 | 38.3% | ||
| 71-80 | 45,662 | 24.6% | 36,474 | 22.6% | 9,188 | 38.5% | 9,829 | 20.7% | 4,916 | 20.7% | 4,913 | 20.7% | ||
| ≥81 | 23,561 | 12.7% | 18,619 | 11.5% | 4,942 | 20.7% | 0 | 0.0% | 0.0% | 0.0% | ||||
| Gender | ||||||||||||||
| Female | 107,955 | 58.2% | 86,194 | 53.3% | 21,761 | 91.2% | <0.001 | 43,265 | 91.1% | 21,631 | 91.1% | 21,634 | 91.1% | 0.96 |
| Male | 77,581 | 41.8% | 75,479 | 46.7% | 2,102 | 8.8% | 4,207 | 8.9% | 2,105 | 8.9% | 2,102 | 8.9% | ||
| Insurance | ||||||||||||||
| Commercial | 57,917 | 31.2% | 54,411 | 33.7% | 3,506 | 14.7% | <0.001 | 7,008 | 14.8% | 3,502 | 14.8% | 3,506 | 14.8% | 1.00 |
| Dual | 2,257 | 1.2% | 1,664 | 1.0% | 593 | 2.5% | 1,128 | 2.4% | 564 | 2.4% | 564 | 2.4% | ||
| Medicaid | 41,847 | 22.6% | 37,926 | 23.5% | 3,921 | 16.4% | 7,644 | 16.1% | 3,821 | 16.1% | 3,823 | 16.1% | ||
| Medicare | 83,515 | 45.0% | 67,672 | 41.9% | 15,843 | 66.4% | 31,692 | 66.8% | 15,849 | 66.8% | 15,843 | 66.7% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 73,292 | 39.5% | 63,797 | 39.5% | 9,495 | 39.8% | 0.33 | 18,870 | 39.7% | 9,434 | 39.7% | 9,436 | 39.8% | 0.99 |
| Yes | 112,244 | 60.5% | 97,876 | 60.5% | 14,368 | 60.2% | 28,602 | 60.3% | 14,302 | 60.3% | 14,300 | 60.2% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.06 | 1.70 | 1.08 | 1.71 | 0.92 | 1.59 | <0.001 | 0.92 | 1.58 | 0.92 | 1.57 | 0.93 | 1.59 | 0.64 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.